142 related articles for article (PubMed ID: 37069829)
21. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
Groeneweg L; Loeffen YGT; Versluys AB; Wolfs TFW
Vaccine; 2021 Jun; 39(25):3338-3345. PubMed ID: 33992440
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients.
Janssen MJM; Bruns AHW; Verduyn Lunel FM; Raijmakers RAP; de Weijer RJ; Nanlohy NM; Smits GP; van Baarle D; Kuball J
Bone Marrow Transplant; 2021 Dec; 56(12):2922-2928. PubMed ID: 34417568
[TBL] [Abstract][Full Text] [Related]
24. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005.
Youssef S; Rodriguez G; Rolston KV; Champlin RE; Raad II; Safdar A
Medicine (Baltimore); 2007 Mar; 86(2):69-77. PubMed ID: 17435587
[TBL] [Abstract][Full Text] [Related]
25. Vaccinations in children with hematologic malignancies and those receiving hematopoietic stem cell transplants or cellular therapies.
Neemann KA; Sato AI
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14100. PubMed ID: 37436808
[TBL] [Abstract][Full Text] [Related]
26. Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
Barkhordar M; Chahardouli B; Biglari A; Ahmadvand M; Bahri T; Alaeddini F; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Biglari M; Shemshadi MR; Ghavamzadeh A; Vaezi M
Front Immunol; 2023; 14():1169666. PubMed ID: 37153556
[TBL] [Abstract][Full Text] [Related]
27. Real-world challenges in eligibility for MMR vaccination two years after autologous and allogeneic HSCT.
Punchhi G; Negus R; Saif H; Pritchard S; Owen O; Sehmbi A; Hamm C
Vaccine; 2023 Sep; 41(41):5936-5939. PubMed ID: 37652820
[TBL] [Abstract][Full Text] [Related]
28. Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers.
Top KA; Pham-Huy A; Price V; Sung L; Tran D; Vaudry W; Halperin SA; De Serres G
Hum Vaccin Immunother; 2016 Apr; 12(4):931-6. PubMed ID: 26962702
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and safety of hepatitis B re-vaccination in children after completion of chemotherapy and(or) hematopoietic stem cell transplantation].
Yuan Q; Zhou F; Zhang H; Cao Q; Chen WJ; Fei Y; Luo CY; Gao YJ
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):802-806. PubMed ID: 32987458
[No Abstract] [Full Text] [Related]
30. Compliance with yellow fever and measles vaccines in the revaccination program post-hematopoietic cell transplantation.
de Almeida Testa LH; Simione AJ; Dos Santos ACF; Colturato I; Barbieri F; de Souza MP; Colturato VR; Machado CM
Transpl Infect Dis; 2023 Aug; 25(4):e14098. PubMed ID: 37428874
[TBL] [Abstract][Full Text] [Related]
31. Poor response to hepatitis A vaccination in hematopoietic stem cell transplant recipients.
Adati EM; da Silva PM; Sumita LM; Rodrigues MO; Zanetti LP; Dos Santos ACF; de Souza MP; Colturato VR; Machado CM
Transpl Infect Dis; 2020 Jun; 22(3):e13258. PubMed ID: 32034983
[TBL] [Abstract][Full Text] [Related]
32. Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination.
Konishi T; Sekiya N; Otsuka Y; Konuma R; Wada A; Adachi H; Kishida Y; Nagata A; Yamada Y; Noguchi Y; Marumo A; Mukae J; Inamoto K; Toya T; Igarashi A; Najima Y; Kobayashi T; Sakamaki H; Ohashi K; Doki N
Int J Hematol; 2021 Aug; 114(2):263-270. PubMed ID: 33846960
[TBL] [Abstract][Full Text] [Related]
33. Reimmunization after hematopoietic stem cell transplantation.
Machado CM
Expert Rev Vaccines; 2005 Apr; 4(2):219-28. PubMed ID: 15889995
[TBL] [Abstract][Full Text] [Related]
34. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice.
Ariza-Heredia EJ; Gulbis AM; Stolar KR; Kebriaei P; Shah DP; McConn KK; Champlin RE; Chemaly RF
Transpl Infect Dis; 2014 Dec; 16(6):878-86. PubMed ID: 25405922
[TBL] [Abstract][Full Text] [Related]
35. Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA).
Miller P; Patel SR; Skinner R; Dignan F; Richter A; Jeffery K; Khan A; Heath PT; Clark A; Orchard K; Snowden JA; de Silva TI
J Infect; 2023 Jan; 86(1):1-8. PubMed ID: 36400155
[TBL] [Abstract][Full Text] [Related]
36. Vaccine Responses in Adult Hematopoietic Stem Cell Transplant Recipients: A Comprehensive Review.
Janssen M; Bruns A; Kuball J; Raijmakers R; van Baarle D
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885251
[TBL] [Abstract][Full Text] [Related]
37. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
Škovránková J; Petráš M
Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
[TBL] [Abstract][Full Text] [Related]
38. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia.
Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I
Transpl Infect Dis; 2019 Apr; 21(2):e13043. PubMed ID: 30585673
[TBL] [Abstract][Full Text] [Related]
39. Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium.
Hudspeth MP; Hill TN; Lewis JA; Van Meter E; Ragucci D
Pediatr Blood Cancer; 2010 Jul; 54(7):970-5. PubMed ID: 20135703
[TBL] [Abstract][Full Text] [Related]
40. Vaccine-preventable disease following allogeneic haematopoietic stem cell transplant in Western Australia.
Ryan AL; Kerr F; Gough H; Carter TL; Kotecha RS
J Paediatr Child Health; 2019 Mar; 55(3):343-348. PubMed ID: 30184291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
